Results 31 to 40 of about 1,406,780 (315)

Research and Discussion on the Supervision of Registration and Sales Units for In Vitro Diagnostic Reagents

open access: yesZhongguo yiliao qixie zazhi
This study reviewed the pre-market regulatory requirements for the division of registration units, registration and filing status, as well as the actual sales and usage status of in vitro diagnostic reagent registration units from the perspective of full
Qinfang DONG   +5 more
doaj   +1 more source

Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization

open access: yesThe Journal of Pediatrics, 2022
To estimate the risk of recurrence of adverse events following immunization (AEFIs) upon revaccination and to determine among patients with suspected vaccine allergy whether allergy skin test positivity was associated with AEFI recurrence.This prospective observational study included patients assessed in the Canadian Special Immunization Clinic Network
Caroline E. Muñoz   +21 more
openaire   +2 more sources

Adverse events

open access: yesBritish Journal of Surgery, 2004
No room for ...
openaire   +2 more sources

Gastrointestinal adverse events of immunotherapy

open access: yesBJR|Open, 2021
Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free survival, but the enhancement of normal immunity can ...
Cappello, Giovanni   +5 more
openaire   +3 more sources

Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events

open access: yes, 2009
Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Christopher J Cates   +5 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Adverse events in British hospitals: preliminary retrospective record review

open access: yes, 2001
Objectives: To examine the feasibility of detecting adverse events through record review in British hospitals and to make preliminary estimates of the incidence and costs of adverse events.
Neale, G.   +3 more
core   +1 more source

Framing healthcare professionals in written adverse events: A discourse analysis

open access: yes, 2021
Healthcare professionals have a major responsibility to protect patients from harm. Despite vast efforts to decrease the number of adverse events, the progression of patient safety has internationally been acknowledged as slow. From a social construction
Kerstin Ulin   +11 more
core   +1 more source

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile

open access: yesNeurology Research International, 2018
Introduction. Adverse events (AEs) associated with antiepileptic drugs (AEDs) affect people with epilepsy’s (PWE) quality of life. A study conducted in 15 European countries showed that the AEs prevalence of AEDs in PWE was up to 80%.
Astri Budikayanti   +4 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy